CRISPR Therapeutics (CRSP) Earnings
|
Expand Research on CRSP
| Next EPS Date | 8/10/26 | EPS Growth Rate | +50.4% |
|---|---|---|---|
| Average EPS % Beat Rate | -28.0% | Revenue Growth Rate | +696.6% |
| Average % Move 1-Wk after EPS | +4.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q226 | N/A | -$1.19 | N/A | N/A | $7.09M | N/A | N/A | N/A | ||
| 5/11/26 |
Q126 | N/A | -$1.23 | N/A | N/A | $5.5M | N/A | N/A | N/A | ||
| 2/12/26 |
Q425 | -$1.37 | -$1.17 | -$0.20 | $860K | $5.66M | N/A |  | | Details | |
| 11/10/25 | Q325 | -$1.17 | -$1.26 | +$0.09 | $890K | $9.41M | N/A | | | Details | |
| 11/7/25 |
Q325 | N/A | -$1.26 | N/A | N/A | $9.41M | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$1.26 | N/A | N/A | $9.41M | N/A | N/A | N/A | ||
| 11/3/25 |
Q325 | N/A | -$1.26 | N/A | N/A | $9.41M | N/A | N/A | N/A | ||
| 10/31/25 |
Q325 | N/A | -$1.26 | N/A | N/A | $9.41M | N/A | N/A | N/A |
